Cigna's PBM expands low-copay access to popular GLP-1s The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company's pharmacy benefits unit Evernorth ...

Dropped FILE PHOTO: Zepbound has been replaced with Wegovy for customers of CVS Caremark. (DOUGLAS SACHA/Douglas - stock.adobe.com) ByCox Media Group National Content Desk July 01, 2025 at 1:16 pm EDT ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 lawsuit for allegedly improperly approving more than $4.3 million for ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S. pharmacy claims.

The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.

Wegovy will now be the GLP-1 weight loss drug of choice under plans that are managed by CVS Caremark. If they stay on Zepbound for their GLP-1 weight loss treatment, they will have to pay full ...